Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/12/2014 - 04/28/2017

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Oxytocin, a naturally-occurring hormone, has been of increasing interest to clinical researchers for possible effects on symptoms of multiple CNS disorders, including anxiety disorders, autism-spectrum, mood disorders, addiction, and schizophrenia. Within the last four years, several studies have reported effects of adjunctive oxytocin administration on persons with schizophrenia treated with antipsychotics. Negative symptoms of schizophrenia are particularly challenging to treat, and there is a great need for interventions targeting this symptom domain. This talk will briefly review negative symptoms of schizophrenia and the efficacy of available antipsychotic medications in treating these symptoms. The focus of this talk will then shift to the safety, mechanism of action, and current body of evidence surrounding the use of adjunctive oxytocin for the treatment of negative symptoms of schizophrenia.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Learning Objectives

  1. Describe negative symptoms in schizophrenia and their relationship to functional outcome in this illness.
  2. Summarize the efficacy of antipsychotics on negative symptoms.
  3. Discuss role of oxytocin in the management of negative symptoms in schizophrenia.
  4. Explain the mechanism of action and safety data of oxytocin in schizophrenia treatment.

Continuing Education Credit and Disclosures

Activity Dates: 06/12/2014 - 04/28/2017
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-14-012-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hours (0.10 CEUs) of knowledge-based continuing education credit. The ACPE universal program number assigned to this course is 0284-0000-14-012-H01-P (1.0 contact hours).